Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07354958

Impact of Diabetes-Related Metabolic Derangements on Clinical Outcomes in Hospitalized Patients With Chronic Kidney Disease

This observational study will collect clinical and laboratory information from hospitalized patients with chronic kidney disease to identify diabetes mellitus and selected metabolic findings during hospitalization

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Hospitalized adult patients with chronic kidney disease will be included in this observational study. Information routinely recorded during hospitalization will be collected. This information will include the presence of diabetes mellitus and laboratory values related to blood glucose levels, electrolyte levels, and acid base balance. No study related interventions will be performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than or equal to 18 years
  • Known chronic kidney disease, defined as baseline estimated glomerular filtration rate less than 60 milliliters per minute per 1.73 square meters for at least 3 months, or documented chronic kidney disease stage 3 to 5 by prior medical records
  • Hospitalized for any medical reason
  • Consent provided

Exclusion criteria

  • Acute single episode of reversible acute kidney injury with previously normal renal function (no established chronic kidney disease)
  • Admission for palliative care or expected survival less than 24 hours
  • Pregnancy

Treatment and study plan

Primary aim 1. To assess the frequency of diabetes mellitus among hospitalized CKD patients. 2. To evaluate the frequency and types of metabolic abnormalities (e.g., hypoglycemia, diabetic ketoacidosi

Behavioral

Primary aim

  • To assess the frequency of diabetes mellitus among hospitalized CKD patients.
  • To evaluate the frequency and types of metabolic abnormalities (e.g., hypoglycemia, diabetic ketoacidosis/ hyperosmolar states, metabolic acidosis, dyslipidemia, electrolyte imbalance) in diabetic CKD patients.

Secondary aim

  • To evaluate the association between diabetes and diabetes-related metabolic derangements in-hospital adverse outcomes (major cardiovascular events, ICU admission, length of stay, infection rate, need for dialysis and mortality) among hospitalized patients with CKD.

Primary outcomes

  1. In-Hospital Mortality

    Time frame: From admission until hospital discharge, assessed over a 6-month study enrollment period.

    Patient death from any cause occurring during the hospitalization period

  2. New Requirement for In-Hospital Renal Replacement Therapy

    Time frame: From admission until hospital discharge, assessed over a 6-month study enrollment period.

    Initiation of dialysis in a patient who was not receiving renal replacement therapy at the time of hospital admission

  3. Incidence of a Major In-Hospital Cardiovascular Composite Event

    Time frame: From admission until hospital discharge, assessed over a 6-month study enrollment period.

    A composite outcome defined as the first occurrence of any of the following during the hospitalization: myocardial infarction, stroke, or new-onset heart failure requiring inotropic support or mechanical ventilation

Study contacts

Contact information is provided by the study sponsor or research team.

Mahmoud Ibrahim Yousef, Associate Professor

CONTACT

[email protected]

01065964083

Mohamed Mahmoud Rashad, Master Degree

CONTACT

[email protected]

01153640803

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 21, 2026
Registry last updated
Jan 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.